NEUP Earnings Neuphoria Therapeutics Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–12 of 12
| Q3 2026 | 2026-03-31 | -2.11 | 2026-05-15 | 10-Q |
| Q2 2025 | 2025-12-31 | -2.66 | 2026-02-17 | 10-Q |
| Q1 2025 | 2025-09-30 | -4.41 | 2025-11-14 | 10-Q |
| FY 2025 | 2025-06-30 | -0.23 | 2025-09-29 | 10-K |
| Q3 2026 | 2025-03-31 | 5.56 | 2026-05-15 | 10-Q |
| Q2 2025 | 2024-12-31 | -4.59 | 2026-02-17 | 10-Q |
| Q1 2025 | 2024-09-30 | -0.62 | 2025-11-14 | 10-Q |
| FY 2025 | 2024-06-30 | -18.62 | 2025-09-29 | 10-K |
| Q3 2025 | 2024-03-31 | -15.20 | 2025-05-20 | 10-Q |
| Q2 2025 | 2023-12-31 | -12.96 | 2025-02-14 | 10-Q |
| Q1 2025 | 2023-09-30 | 0.00 | 2024-11-14 | 10-Q |
| FY 2024 | 2023-06-30 | -0.02 | 2024-09-30 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.